Skip to main content

Month: September 2021

RAMSAY SANTE : date of approval of the final consolidated financial statements for the year ending June 2021

        PRESS RELEASE Paris, 21 September 2021 Date of approval of the final consolidated financial statements for the year ending June 2021 In its press release of August 25, 2021 relating to the publication of the provisional annual results at the end of June 2021, Ramsay Santé indicated that the final consolidated financial statements for the year ended June 2021 would be approved by the Board of Directors at its meeting on September 23, 2021. As the finalization of these financial statements and their review by the auditors will require additional time, it is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021. About Ramsay Santé After the acquisition of Capio AB Group in 2018, Ramsay Santé has become one of the leaders...

Continue reading

Form 8.3 – National Express Group PLC

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbone Brothers PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree National Express Group PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an...

Continue reading

Farmers & Merchants Bancorp, Inc. Receives Regulatory Approval For Perpetual Federal Savings Bank Acquisition

David Vernon Elected to Farmers & Merchants’ Board of Directors ARCHBOLD, Ohio, Sept. 21, 2021 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (“F&M”, “FMAO”, or the “Company”) (Nasdaq: FMAO), the holding company for Farmers & Merchants State Bank, announced today that it has received regulatory approvals for the acquisition of Perpetual Federal Savings Bank of Urbana (“PFSB”). In addition, F&M announced that David Vernon, a current Director of PFSB, will join F&M’s Board of Directors upon the completion of the transaction. Lars Eller, President and CEO of F&M, stated, “I am excited that we will be able to close the PFSB acquisition in under six months demonstrating our growing track record of quickly completing and integrating acquisitions. Of the approximately 64% of votes cast by PFSB...

Continue reading

Rubber Market Size & Outlook 2020-2027 | Rubber Industry Expected to Worth 51.21 Billion During Forecast Period, States Fortune Business Insights™

Top players covered the rubber market are Von Bundit (Thailand), Sri Trang Agro-Industry (Thailand), Southland Holding Lonza (Thailand), Vietnam Rubber Group (Vietnam), Tradewinds Plantation Berhad (Malaysia), ARLANXEO (Netherlands), Kumho Petrochemical Co., Ltd. (South Korea), PetroChina (China), TSRC Corporation (Taiwan), LG Chem (South Korea), Versalis (Italy), Dow Chemicals (U.S.), Tong Thai Rubber Group (Thailand), Ravasco (India), Halcyon Agri (Singapore), Unitex Rubber (Thailand) and more companies profiled Pune, India, Sept. 21, 2021 (GLOBE NEWSWIRE) — The global rubber market size is expected to reach USD 51.21 billion by 2027, exhibiting a CAGR of 5.3% during the forecast period. The growing demand for tires and other automotive parts will simultaneously spur opportunities during the forecast period. The growing utilization...

Continue reading

Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings

Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listing CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, through an extensive, established European Union distribution network, today announced that the Company has entered into agreements for investments of approximately $5.5 million from a subsidiary of Ault Global Holdings, Inc. (NYSE American: DPW) (“Ault Global”). The first investment, a convertible promissory note, resulted in immediate net proceeds of approximately $500,000. The...

Continue reading

Healixa Visits Guyana to Meet with Government Ministers and UNICEF

New York, New York and Georgetown, Guyana, Sept. 21, 2021 (GLOBE NEWSWIRE) — Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, and Vitality Inc, a seasoned local Guyanese company led by socially-minded entrepreneurs announced today that they met with several Minsters of Guyana and UNICEF organized by Anter Narine, a prominent business leader promoting bi-lateral relationships between US and Guyanese companies.   Mr. Narine said, “The US and Guyanese businesses are teaming up to deliver highly sophisticated projects that include climate resilient water infrastructure, virtual high quality accessible health care, and clean energy. I was delighted to hear of how both...

Continue reading

The RealReal Names Robert Julian Chief Financial Officer

SAN FRANCISCO, Sept. 21, 2021 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced Robert Julian is joining the company as Chief Financial Officer (CFO) on Oct. 1. Julian has extensive experience helming finance organizations at public companies, having previously served as CFO of Sportsman’s Warehouse, Callaway Golf and Lydall. He also held CFO roles at Deluxe Entertainment Services Group and Legrand North America. “Robert brings both deep public market and operational experience to our management team, a combination that will be incredibly valuable for The RealReal as we progress toward profitability,” said Julie Wainwright, founder and CEO of The RealReal. “I look forward to having him as a close partner and know our entire team will benefit...

Continue reading

On the sanction imposed on Medicinos Bankas

Medicinos Bankas UAB (“Bank”), registration number 112027077, registered seat address: Pamėnkalnio 40, LT-01114 Vilnius, Lithuania. Medicinos Bankas hereby informs that the Bank of Lithuania (BL) has carried out a planned inspection of the Bank’s compliance with the procedures for the prevention of money laundering and terrorist financing (ML/TF). After reviewing the inspection report, the Board of the Bank of Lithuania stated and adopted a resolution that the Bank did not ensure adequate internal control procedures related to the implementation of international financial sanctions, and, therefore, obliged the Bank to correct the deficiencies identified in the field of the AML/TF prevention requirements, and imposed a penalty of EUR 300,000 on the Bank. The Bank informs that a significant part of the deficiencies identified by the BL...

Continue reading

AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board

An Internationally Recognized Authority in Dry Eye Disease, Dr. Tauber has Participated in over 140 Research Studies as Principal InvestigatorJoseph Tauber, MDAXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory BoardSAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced that it has appointed Joseph Tauber, MD as Chief Medical Officer and Chairman of its Medical Advisory Board. With over 30 years of clinical experience, Dr. Tauber is an internationally recognized authority in the field of ocular surface diseases including dry eye and meibomitis management. He...

Continue reading

Skye Bioscience Announces THCVHS Late-Breaking Preclinical Abstracts Selected by American Association of Pharmaceutical Scientists Meeting PharmSci 360

SAN DIEGO, CA, Sept. 21, 2021 (GLOBE NEWSWIRE) —  Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, announced today its research partner, the University of Mississippi will present late-breaking preclinical data evaluating different nanoemulsion formulations of its prodrug of tetrahydrocannabinol (THC), THCVHS, in addition to the superiority of THCVHS, in lowering intraocular pressure in dutch belted rabbits when co-administered with netarsudil, a rho-kinase inhibitor, at the 2021 American Association of Pharmaceutical Scientists Meeting (AAPS) PharmSci 360 being held October 17 -20, 2021, at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Details of late-breaking poster presentations: Title:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.